Search Results
Checkpoint inhibitors for cutaneous lymphoma: the way of the future?
Future directions for checkpoint inhibitors in cutaneous lymphoma treatment
New and future treatments for lymphoma - Prof Andy Davies
CD47-blocking checkpoint inhibitor TTI-621 shows promising results for cutaneous T-cell lymphomas
Update on Cutaneous T-Cell Lymphoma | Lymphoma Research Foundation Webinars
Understanding Immunotherapy for the Treatment of Lymphoma with Elise Chong, MD
Quality of life in cutaneous lymphoma patients: patient-reported outcomes
Curing metastatic solid tumours with immune checkpoint inhibitors by Professor James Larkin
Immunotherapy in Lymphomas – the Present and the Future | Manali Kamdar, MD
Regulation of PD-L1 in cutaneous lymphoma by miRNAs
What is in the future for T-cell lymphoma?
2-Day Conference: Cutaneous Lymphoma Research and Science
